[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-335452-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-335452-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","cancer-and-mortality-risks-among-people-with-multiple-sclerosis-a-population-based-study-in-isfahan-iran","Cancer and mortality risks among people with multiple sclerosis - A population-based study in Isfahan, Iran","","Background: Multiple sclerosis (MS) and cancer are major global health challenges, and cancer patterns in people with MS may vary by demographics and region. Objective: Investigate the association between cancer risk and MS using population-level data from Isfahan province, Iran. Methods: MS cohorts were identified via the National Multiple Sclerosis Registry System with McDonald-confirmed diagnoses; cancer incidence used the Iranian National Population-Based Cancer Registry, applying descriptive statistics, regression models, and Kaplan-Meier survival analysis. Results: Among 10,049 MS patients, 123 developed cancer; older age and monoclonal antibody therapy increased cancer risk, and male sex and longer MS duration increased cancer mortality risk.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/cancer-and-mortality-risks-among-people-with-multiple-sclerosis-a-population-based-study-in-isfahan-iran/335452/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/cancer-and-mortality-risks-among-people-with-multiple-sclerosis-a-population-based-study-in-isfahan-iran/335452.png","ImageObject",300,407,{"name":42,"@type":43},"Skyler","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the document’s main research question?","Question",{"text":63,"@type":64},"It examines the association between cancer risk and multiple sclerosis and evaluates related cancer and mortality risks in a population-based cohort in Isfahan, Iran.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were people with multiple sclerosis identified and verified?",{"text":68,"@type":64},"Data were collected from the National Multiple Sclerosis Registry System of Iran, and diagnoses were confirmed using McDonald criteria by neurologists specialized in MS.",{"name":70,"@type":61,"acceptedAnswer":71},"Which factors were linked to higher cancer risk and cancer mortality risk?",{"text":72,"@type":64},"Receiving monoclonal antibody medications and older age were associated with higher cancer risk, while being male and having longer MS duration were linked to higher cancer mortality risk.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},335452,1790549166,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":108,"preview_page_count":4},2336464648746,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","PLOS ONE  \nOPEN ACCESS  \nCitation: Nafari A, Vaheb S, Afshari-Safavi A, Ravankhah Z, Teimouri F, Shaygannejad V, et al.(2024) Cancer and mortality risks among people with multiple sclerosis: A population-based study in Isfahan, Iran. PLoS ONE 19(10): e0312707 .  \n[https://doi.org/10.1371/journal.pone.0312707](https://doi.org/10.1371/journal.pone.0312707)  \n[Editor:](Editor: Mohammad Reza Fattahi)[ Mohammad Reza Fattahi](Editor: Mohammad Reza Fattahi), King’s College Hospital NHS Trust: King’s College Hospital NHS Foundation Trust, UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND  \nReceived: July 29, 2024  \nAccepted: October 10, 2024  \nPublished: October 31, 2024  \nPeer Review History: PLOS recognizes the benefits of transparency in the peer review process; therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. The editorial history of this article is available here:  \n[https://doi.org/10.1371/journal.pone.0312707](https://doi.org/10.1371/journal.pone.0312707)  \n[Copyright:](Copyright:) © [2024](2024) Nafari et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.  \nData Availability Statement: The data used in this study belongs to the MUI, and we had access to  \nRESEARCH ARTICLE  \nCancer and mortality risks among people with multiple sclerosis: A population-based study in Isfahan, Iran  \nAmirhossein Nafari1‡, Saeed Vaheb1‡, Alireza Afshari-Safavi1,2, Zahra Ravankhah3, Fotooheh Teimouri3, Vahid Shaygannejad1,4 *, Omid Mirmosayyeb1,4  \n1 Isfahan Neurosciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran,  \n2 Department of Biostatistics and Epidemiology, Faculty of Health, North Khorasan University of Medical Sciences, Bojnurd, Iran, 3 Department of Noncommunicable Disease, Faculty University of Medical Sciences, Isfahan, Iran, 4 Department of Neurology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran  \n‡ AN and SV contributed equally to this work as first authors.  \n* [v.shaygannejad@gmail.com](v.shaygannejad@gmail.com)  \nAbstract  \nBackground  \nMultiple sclerosis (MS) and cancer present substantial global health challenges. Understanding cancer patterns among people with MS (PwMS) is crucial due to potential variations across demographics and geographic regions. Isfahan province in Iran, known for its high MS incidence ratio, offers a significant population for comprehensive studies on MS. In this study, we aim to investigate the association between risk of cancer and MS.  \nMethod  \nData on PwMS were collected utilizing the National Multiple Sclerosis Registry System of Iran (NMSRI), with diagnoses confirmed using McDonald criteria by neurologists specialized in MS. Cancer incidence was investigated using the Iranian National Population-Based Cancer Registry (INPCR) data, collected following international protocols. Descriptive statistics and regression analyses were employed to assess factors associated with cancer and mortality risks among PwMS. Survival analysis was conducted using Kaplan-Meier curves.  \nResults  \nOut of 10,049 PwMS, 123 were diagnosed with cancer, with an mean age at the time of cancer diagnosis being 40.41 years and a mean MS duration of 6.76 years. The majority had relapsing-remitting MS (81.2%), and Interferon-β was the most common disease-modifying therapy (DMT) (42 .4%) . Cancer incidence was 125.6 per 100,000 person-years, peaking at ages 60–64 (677 .9 per 100,000 person-years) . Receiving monoclonal antibody medicationsand older age were significantly associated with higher cancer risk (OR:1 .542 (1 .009– 2.357), OR:1 .033 (1 .015–1.051), respectively) . Female breast cancer had the highest incidence ratio among PwMS (40 . 17 per 100,000 person-years), followed by thyroid (18 .38 per 10","cbCaiovsoquJfGbM","https://ap.wps.com/l/cbCaiovsoquJfGbM","pdf",739190,16,"English","# Abstract\n## Background\n## Method\n## Results\n## Conclusion\n# Introduction\n## Multiple sclerosis and comorbid cancer","[{\"question\":\"What is the document’s main research question?\",\"answer\":\"It examines the association between cancer risk and multiple sclerosis and evaluates related cancer and mortality risks in a population-based cohort in Isfahan, Iran.\"},{\"question\":\"How were people with multiple sclerosis identified and verified?\",\"answer\":\"Data were collected from the National Multiple Sclerosis Registry System of Iran, and diagnoses were confirmed using McDonald criteria by neurologists specialized in MS.\"},{\"question\":\"Which factors were linked to higher cancer risk and cancer mortality risk?\",\"answer\":\"Receiving monoclonal antibody medications and older age were associated with higher cancer risk, while being male and having longer MS duration were linked to higher cancer mortality risk.\"}]","Cancer and mortality risks among people with multiple sclerosis - A population-based study in Isfahan, Iran | PDF",1790011030]